ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $341,021 | -21.6% | 51,051 | -1.5% | 0.00% | – |
Q2 2023 | $434,703 | +63.1% | 51,812 | +93.0% | 0.00% | – |
Q1 2023 | $266,541 | +49.2% | 26,842 | +4.6% | 0.00% | – |
Q4 2022 | $178,656 | +24.1% | 25,669 | -5.1% | 0.00% | – |
Q3 2022 | $144,000 | +15.2% | 27,049 | -13.4% | 0.00% | – |
Q2 2022 | $125,000 | +6.8% | 31,226 | +18.7% | 0.00% | – |
Q1 2022 | $117,000 | +34.5% | 26,306 | +21.2% | 0.00% | – |
Q4 2021 | $87,000 | -78.4% | 21,697 | -52.7% | 0.00% | – |
Q3 2021 | $403,000 | -23.2% | 45,847 | -1.1% | 0.00% | – |
Q2 2021 | $525,000 | +98.1% | 46,342 | +107.8% | 0.00% | – |
Q1 2021 | $265,000 | +69.9% | 22,300 | -2.2% | 0.00% | – |
Q4 2020 | $156,000 | -7.7% | 22,798 | 0.0% | 0.00% | – |
Q3 2020 | $169,000 | +83.7% | 22,798 | +3.2% | 0.00% | – |
Q2 2020 | $92,000 | +50.8% | 22,100 | -10.2% | 0.00% | – |
Q1 2020 | $61,000 | -53.4% | 24,600 | +8.8% | 0.00% | – |
Q4 2019 | $131,000 | +12.0% | 22,600 | +1.8% | 0.00% | – |
Q3 2019 | $117,000 | +13.6% | 22,200 | +29.8% | 0.00% | – |
Q2 2019 | $103,000 | – | 17,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 1,009,131 | $7,568,000 | 1.15% |
Knoll Capital Management, LLC | 124,096 | $931,000 | 0.96% |
683 Capital Management, LLC | 1,000,000 | $7,500,000 | 0.66% |
Perceptive Advisors | 3,085,458 | $23,141,000 | 0.65% |
MANGROVE PARTNERS IM, LLC | 324,019 | $2,430,000 | 0.16% |
Stanley-Laman Group, Ltd. | 64,029 | $480,000 | 0.11% |
WOODSTOCK CORP | 67,759 | $508,000 | 0.10% |
Hikari Power Ltd | 107,858 | $809,000 | 0.10% |
ARDSLEY ADVISORY PARTNERS LP | 45,000 | $336,000 | 0.05% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 750,000 | $5,625,000 | 0.01% |